Mean levels of S-PTH were less than 6.9 pmol/L in both study groups, and there was no significant difference in the rates of secondary hyperparathyroidism (defined as S-PTH >6.9 pmol/L) (SMD<0.1, Table 1). The gene discussed is PTH; the disease is secondary hyperparathyroidism.